Healthcare Industry News:  Positron Corporation 

Devices Radiology Cardiology Personnel

 News Release - June 4, 2010

Positron Announces the Addition of South Central Regional Sales Representative

INDIANAPOLIS--(HSMN NewsFeed)--Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, announced today that Michael Stewart, BSRT, CNMT has joined Positron as its new South Central Regional Sales Representative. Mr. Stewart will be responsible for growing Positron’s sales of their Attrius(TM) cardiac optimized PET molecular imaging system throughout the region.

Mr. Stewart brings seventeen years of industry relationships and experience in the Nuclear Medicine arena; specifically in clinical diagnostic imaging, corporate accounts, medical devices and radiopharmaceutical sales. He holds a B.S. in Radiologic Technology with an emphasis in nuclear medicine from the University of Central Arkansas.

Positron Corporation's Chief Technology Officer, Mr. Joseph Oliverio, stated, "The addition of Michael Stewart to our team provides us with valuable experience from his clinical background in addition to his knowledge of pharmaceutical and medical device industry. We are confident he will help accelerate sales of the Attrius(TM) system in that region.”

Mr. Stewart stated, "I am excited about joining Positron, as I strongly believe they are ideally positioned within the nuclear cardiology market with the only dedicated PET currently offered. I look forward to helping them rapidly expand their install base."

About Positron: Positron founded in 1983, is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging systems to radiopharmaceutical distribution. Positron products include: the Attrius(TM), a PET imaging device; the Pulse®, a SPECT imaging device; the Nuclear Pharm-Assist®, an automated radiopharmaceutical distribution device; and the Tech-Assist(TM), a radiopharmaceutical injection shield. Positron is headquartered in Indianapolis, Indiana. More information about Positron is available at

Forward Looking Statements: Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance and may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission.

For further information please contact Positron Corporation at (317) 576-0183.

Source: Positron Corp

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.